KEGG   DRUG: Darunavir, cobicistat, emtricitabine and tenofovir alafenamideHelp
Entry
D11382            Mixture   Drug                                   

Name
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide;
Symtuza (TN)
Product
Component
(Darunavir [DR:D03656] | Darunavir ethanolate [DR:D06478]), Cobicistat [DR:D09881], Emtricitabine [DR:D01199], (Tenofovir alafenamide [DR:D10428] | Tenofovir alafenamide fumarate [DR:D10605])
Remark
Therapeutic category: 6250
ATC code: J05AR22
Product: D11382<US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Interaction
Drug interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR22 Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
      D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Agents, Other
   Darunavir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Fumarate
    D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D11382  Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11382
BRITE hierarchy
Other DBs
PubChem: 384585360
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system